Phio Pharmaceuticals Corp. Modification Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Engagement Agreement between RXi Pharmaceuticals Corporation and H.C. Wainwright & Co., LLC (April 20, 2015)
Modification Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2015
Seventh Amendment to Securities Purchase Agreement among Galena Biopharma, RXi Pharmaceuticals, Tang Capital Partners, and RTW Investments
Modification Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2012
Sixth Omnibus Amendment to Securities Purchase Agreement and Bridge Notes by Galena Biopharma, RXi Pharmaceuticals, Tang Capital Partners, and RTW Investments
Modification Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2012
Fifth Omnibus Amendment to Securities Purchase Agreement and Bridge Notes by Galena Biopharma, RXi Pharmaceuticals, Tang Capital Partners, and RTW Investments
Modification Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2012
Fourth Omnibus Amendment to Securities Purchase Agreement and Bridge Notes by Galena Biopharma, RXi Pharmaceuticals, Tang Capital Partners, and RTW Investments
Modification Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2012
Third Omnibus Amendment to Securities Purchase Agreement and Bridge Notes by Galena Biopharma, RXi Pharmaceuticals, Tang Capital Partners, and RTW Investments
Modification Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2012
Second Omnibus Amendment to Securities Purchase Agreement and Bridge Notes by Galena Biopharma, RXi Pharmaceuticals, Tang Capital Partners, and RTW Investments
Modification Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2012
Omnibus Amendment to Securities Purchase Agreement and Bridge Notes among Galena Biopharma, RXi Pharmaceuticals, Tang Capital Partners, and RTW Investments (February 6, 2012)
Modification Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2012
Omnibus Amendment to Securities Purchase Agreement and Bridge Notes among Tang Capital Partners, RTW Investments, Galena Biopharma, and RXi Pharmaceuticals (February 6, 2012)
Modification Agreements
Phio Pharmaceuticals Corp.
Biotechnology
2012